Thailand’s medical devices market was valued at USD 2.23 billion in 2024, shaped by a rebound in import activity and rising healthcare demand. Device imports grew by 11.0% in USD terms in 2023, with strong momentum in consumables and orthopaedic products. Demand is concentrated around Bangkok and major urban centers such as Chiang Mai and Phuket, where hospitals and specialist clinics serve domestic patients and medical travelers. Trade.gov also links demand to continuous investment in hospitals by private-sector healthcare providers, alongside growing awareness and interest in health and wellness globally.
Product and buyer mix explain why manufacturing strategies often start with high-volume categories. Consumables hold a 40% share of the Thai medical devices market, driven by frequent replacement cycles in hospitals and clinics and robust import volumes in 2023. Nexdigm notes that items such as surgical gloves, syringes, and bandages remain areas where Thailand relies heavily on imports due to limited domestic production capability. On the demand side, public hospitals command the largest end-user share at 35%, supported by government-backed frameworks such as Universal Health Coverage and substantial public healthcare spending. This creates stable, high-volume procurement cycles that can anchor local supply plans.
Why BOI-Backed Manufacturing Is Gaining Attention
Manufacturing interest is increasingly tied to medical tourism, export pull, and promotion incentives. Trade.gov cites Siam Commercial Bank’s Economic Intelligence Center, which forecast Thailand’s medical tourism market at $829 million in 2023, with foreign patients coming from CLMV countries, the Middle East, and China. MedExport Asia reports exports reaching US$5B in 2020 and says the sector had over 513 active companies, led by SMEs producing single-use and durable devices, while high-tech imports continued to grow. It also describes BOI incentives as a support factor, alongside rising R&D and a shift narrative from consumables exports toward innovation such as AI-driven health tech and biopharma.
Contract manufacturing data highlights a concrete channel for scaling production in Thailand. Grand View Research estimates Thailand’s medical device contract manufacturing market generated USD 333.6 million in 2024 and is expected to reach USD 712.9 million by 2030, growing at a CAGR of 13.8% from 2025 to 2030. It also states that Class II was the largest segment, with a 91.13% revenue share in 2024. In practice, this points to where capacity, compliance work, and customer demand are currently clustering. For investors and manufacturers, the message is that growth is not only about selling devices locally, but also about building reliable production programs that fit regulated device classes.
Competition and capability gaps still shape how companies approach localization. Nexdigm describes a market featuring global multinationals and local players, reflecting import dependence and domestic supply constraints. Major companies named include Medtronic, Johnson & Johnson, Stryker, GE Healthcare, and Philips Healthcare, particularly in advanced therapeutic, imaging, and diagnostic segments. Andaman Medical adds that Thailand is home to around 500 medical device manufacturers, spanning SMEs to multinational corporations, and notes BOI promotion incentives for local manufacture of medical robotics. Together, the sources frame a sector where imports remain important, but BOI-backed manufacturing and contract production offer clearer pathways to deepen local value creation.
How large is Thailand’s medical devices market in recent estimates?
Which product category leads demand in Thailand’s device market mix?
What does the outlook show for Thailand’s medical device contract manufacturing market?
How does medical tourism connect to device demand in Thailand?
What are key signals that the Thailand medical device industry is becoming a BOI-backed growth sector?
